Cadila Pharmaceuticals Limited — Fexofenadine Exporter Profile
Indian Pharmaceutical Exporter · #15 for Fexofenadine · $1.6M export value · DGFT Verified
Cadila Pharmaceuticals Limited is the #15 Indian exporter of Fexofenadine with $1.6M in export value and 74 verified shipments. Cadila Pharmaceuticals Limited holds a 1.5% market share in Fexofenadine exports across 9 countries. The company exports 15 pharmaceutical products worth $20.2M across 11 therapeutic categories.
Cadila Pharmaceuticals Limited — Fexofenadine Export Profile: Buyers & Destinations
Where Does Cadila Pharmaceuticals Limited Export Fexofenadine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $763.6K | 23 | 61.2% |
| UNITED ARAB EMIRATES | $227.9K | 7 | 18.3% |
| PERU | $179.2K | 18 | 14.4% |
| ZIMBABWE | $21.9K | 5 | 1.8% |
| YEMEN | $19.0K | 4 | 1.5% |
| YEMEN, DEMOCRATIC | $17.4K | 4 | 1.4% |
| ZAMBIA | $8.4K | 6 | 0.7% |
| YEMEN DEMOCRATIC | $4.7K | 3 | 0.4% |
| SRI LANKA | $3.8K | 2 | 0.3% |
| KENYA | $826 | 2 | 0.1% |
Cadila Pharmaceuticals Limited exports Fexofenadine to 10 countries. The largest destination is AUSTRALIA accounting for 61.2% of Cadila Pharmaceuticals Limited's Fexofenadine shipments, followed by UNITED ARAB EMIRATES (18.3%) and PERU (14.4%). These destinations reflect Cadila Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fexofenadine from Cadila Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ARROW PHARMACEUTICALS PTY LTD. | AUSTRALIA | $350.5K | 13 |
| ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $303.5K | 7 |
| LIFE PHARMA FZE | UNITED ARAB EMIRATES | $227.9K | 7 |
| CAFERMA S.A.C | PERU | $141.6K | 16 |
| ARROW PHARMACEUTICALS PTY LIMITED | AUSTRALIA | $109.6K | 3 |
| CAFERMA S A C | PERU | $37.6K | 2 |
| AL-JABAL DRUGS & MEDICAL APPLIANCES | YEMEN, DEMOCRATIC | $30.2K | 6 |
| SKY PHARMACEUTICALS (PVT) LTD | ZIMBABWE | $13.6K | 4 |
| YASH PHARMACEUTICALS LTD | ZAMBIA | $8.4K | 6 |
| SKY PHARMACEUTICALS PVT LTD | ZIMBABWE | $8.3K | 1 |
Cadila Pharmaceuticals Limited supplies Fexofenadine to 15 buyers globally. The largest buyer is ARROW PHARMACEUTICALS PTY LTD. (AUSTRALIA), followed by ARROW PHARMACEUTICALS PTY LTD (AUSTRALIA) and LIFE PHARMA FZE (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fexofenadine Export Value and How Much Does Cadila Pharmaceuticals Limited Contribute?
India exported $81.9M worth of Fexofenadine through 4,236 shipments from 224 suppliers to 97 countries, serving 599 buyers globally. Cadila Pharmaceuticals Limited contributes $1.6M to this total, accounting for 1.5% of India's Fexofenadine exports. Cadila Pharmaceuticals Limited ships Fexofenadine to 10 countries through 15 buyers.
What Is the Average Shipment Value for Cadila Pharmaceuticals Limited's Fexofenadine Exports?
Cadila Pharmaceuticals Limited's average Fexofenadine shipment value is $21.5K per consignment, based on 74 shipments totaling $1.6M. The largest destination is AUSTRALIA (61.2% of Cadila Pharmaceuticals Limited's Fexofenadine exports).
How Does Cadila Pharmaceuticals Limited Compare to Other Indian Fexofenadine Exporters?
Cadila Pharmaceuticals Limited ranks #15 among 224 Indian Fexofenadine exporters with a 1.5% market share. The top 3 exporters are IND SWIFT LIMITED ($14.6M), CIPLA LIMITED ($13.6M), DR.REDDY'S LABORATORIES LTD ($12.4M). Cadila Pharmaceuticals Limited processed 74 shipments to 9 destination countries.
What Fexofenadine Formulations Does Cadila Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CHEMISTS OWN FEXO 180MG TABLET (R/M : FEXOFENADINE HYDROCHLORIDE) BATCH BY05E4009 TO BY05E4016 (ASPERINV) | $143.3K | 3 |
| CHEMISTS OWN FEXO 180MG TABLET (R/M : FEXOFENADINE HYDROCHLORIDE) BATCH BY05E4005 TO BY05E4008 MFG-APR-2024 EXP-MAR-2027 | $89.2K | 3 |
| CHEMISTS OWN FEXO 180MG TABLET (R/M : FEXOFENADINE HYDROCHLORIDE) BATCH BY05E4002 TO BY05E4004 (ASPERINV) | $59.1K | 3 |
| PHARMACEUTICALS PRODUCT. FEXAFEX 180 (1X10T) RM: FEXOFENADINE HCL PH. EUR. BATCHET883E4003 TO ET883E4010 (AS PER INV) | $54.7K | 3 |
| TELIFE 120 (R/M : FEXOFENADINE HCL TAB) | $50.0K | 1 |
| TELIFE 180 (R/M : FEXOFENADINE HCL TAB) | $50.0K | 1 |
| CHEMISTS OWN FEXO 180MG TABLET R/M : FEXOFENADINE HYDROCHLORIDE BATCH BY05E3024-3027 MANUFACTURING Dt-SEP-2023 Exp Dt-AUG-2026 | $50.0K | 1 |
| TELIFE 180 (R/M : FEXOFENADINE HCl TAB) BATCH BY05E5003 TO BY05E5006 Mfg Dt-MAR-2025 Exp Dt-FEB-2028 | $50.0K | 1 |
| CHEMISTS OWN FEXO 180MG TABLET R M FEXOFENADINE HYDROCHLORIDE BATCH BY05E5011 TO BY05E5014 AS PER INVOICE | $50.0K | 1 |
| PHARMACEUTICAL PRODUCT CHEMISTS OWN FEXO180MG TABLET RAW MATERIAL FEXOFENADINEHYDROCHLORIDE BATNO BY05E5007TO10 ASINV | $50.0K | 1 |
Cadila Pharmaceuticals Limited exports 47 distinct Fexofenadine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CHEMISTS OWN FEXO 180MG TABLET (R/M : FEXOFENADINE HYDROCHLO with 3 shipments worth $143.3K.
Regulatory Requirements: Exporting Fexofenadine to Key Markets
What Cadila Pharmaceuticals Limited must comply with to export Fexofenadine to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cadila Pharmaceuticals Limited Compare to Nearest Fexofenadine Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | DR.REDDY'S LABORATORIES LIMITED | $1.7M | 48 | 2 | $36.3K |
| 14 | ZENTIVA PRIVATE LIMITED | $1.7M | 48 | 1 | $36.0K |
| 15 | CADILA PHARMACEUTICALS LIMITED ★ | $1.6M | 74 | 9 | $21.5K |
| 10 | DR REDDY S LABORATORIES LIMITED | $1.1M | 23 | 3 | $50.0K |
| 13 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $800.0K | 16 | 1 | $50.0K |
Cadila Pharmaceuticals Limited ranks #15 among 224 Indian Fexofenadine exporters. Average shipment value of $21.5K compared to the market average of $365.5K. The closest competitors by value are DR.REDDY'S LABORATORIES LIMITED and ZENTIVA PRIVATE LIMITED.
Which Indian Ports Ship Fexofenadine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 569 | 13.4% |
| JNPT/ NHAVA SHEVA SEA | 385 | 9.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 362 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 350 | 8.3% |
| HYDERABAD ICD | 229 | 5.4% |
| CHAWAPAYAL ICD | 186 | 4.4% |
| JNPT | 161 | 3.8% |
| CHAWAPAYAL ICD (INCPR6) | 142 | 3.4% |
Geopolitical & Trade Policy Impact on Cadila Pharmaceuticals Limited's Fexofenadine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Cadila Pharmaceuticals. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, causing major carriers to suspend or reroute transits. This has resulted in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the timely delivery of pharmaceuticals. (livemint.com)
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. However, the U.S. has also implemented tariffs on Active Pharmaceutical Ingredients (APIs), leading to a reshoring of manufacturing and affecting Indian firms. In response, some Indian companies have invested in U.S. facilities to circumvent these tariffs. (odrindia.in)
In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. Indian exporters must ensure stringent adherence to these regulations to maintain market access, necessitating investments in serialization and traceability systems.
Cadila Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is crucial for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) has previously issued warnings to Cadila Pharmaceuticals regarding deviations from standard manufacturing practices. (business-standard.com) To address such concerns, the company has invested in enhancing its quality control systems and manufacturing processes. Additionally, Cadila has engaged in legal proceedings concerning biosimilar approvals, highlighting the complexities of regulatory compliance in the biosimilars market. (legaleraonline.com)
About Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited exports 15 products worth $20.2M. Beyond Fexofenadine, top products include Mebendazole, Verapamil, Folic, Domperidone, Ethambutol. View the complete Cadila Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fexofenadine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fexofenadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cadila Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 74 individual customs records matching Cadila Pharmaceuticals Limited exporting Fexofenadine, covering 47 formulations to 10 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 599+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fexofenadine Export Data from Cadila Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cadila Pharmaceuticals Limited's Fexofenadine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cadila Pharmaceuticals Limited
Full Company Profile →
15 products · $20.2M total trade · 11 categories
Fexofenadine Stats
Company Overview
Top Products by Cadila Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cadila Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fexofenadine. For current shipment-level data, contact TransData Nexus.